2722 B. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS

BACKGROUND: The quadrivalent meningococcal ACWY polysaccharide tetanus toxoid conjugate vaccine (MenACWY-TT; Nimenrix) is licensed in various countries to prevent disease caused by meningococcal serogroups A, C, W, and Y. In a previous study (NCT00464815), subjects aged 11‒17 years received a primar...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiambao, Beatriz, Peyrani, Paula, Webber, Chris, Van Der Wielen, Marie, Bianco, Veronique, Perez, John L, Cutler, Mark W, Li, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810409/
http://dx.doi.org/10.1093/ofid/ofz360.2406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810409/
http://dx.doi.org/10.1093/ofid/ofz360.2406

Ejemplares similares